Acceptance and Commitment Therapy (ACT) vs Erenumab for High Frequency Episodic Migraine Without Aura: Time to Take the Gloves Off!

Grazzi, Licia; Rizzoli, Paul

doi:10.1111/head.13776

Cited by 7 publications

(13 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While 5 studies were uncontrolled clinical trials [ 91 , 92 , 93 , 94 , 95 ], the remaining 16 did have one or more control group/s. Ten studies were performed in Europe (Sweden, United Kingdom, Spain, Denmark, Italy, Greece and Cyprus) [ 96 , 97 , 98 , 99 , 100 ], five in the USA [ 101 , 102 , 103 , 104 , 105 ], four in Iran [ 106 , 107 , 108 , 109 ], one in Canada [ 110 ], and one in Japan [ 111 ]. More details can be found in Table 1 .…”

Section: Resultsmentioning

confidence: 99%

“…Regarding sex, the samples of seven studies were composed entirely of women [ 93 , 95 , 96 , 97 , 100 , 105 , 109 ], while in ten studies there was a clear female predominance (≥80%) [ 10 , 91 , 92 , 98 , 99 , 100 , 103 , 104 , 108 , 111 ]. Finally, four studies did not report information about subject sex [ 94 , 102 , 106 , 107 ].…”

Section: Resultsmentioning

confidence: 99%

“…ACT has been proposed as an adjunctive or alternative to pharmacologic therapies for the management of episodic migraine [ 102 ], both in the outpatient and hospital setting [ 109 ]. Despite previous positive evidence, further studies are required.…”

Section: Resultsmentioning

confidence: 99%

“…Consensus was achieved either through discussing the interpretation of the criteria again, or via the involvement of a third independent reviewer (G.A.R.P). The ROB evaluation revealed that 12 studies were of low quality [ 93 , 94 , 95 , 98 , 101 , 102 , 103 , 105 , 106 , 107 , 108 , 109 ], 5 were of moderate quality [ 91 , 92 , 96 , 103 , 111 ], and 4 were high quality [ 97 , 99 , 100 , 110 ]. Details on the ROB assessments can be found in Table 2 .…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Effectiveness of Acceptance and Commitment Therapy in Central Pain Sensitization Syndromes: A Systematic Review

Galvez-Sánchez

Montoro

Moreno-Padilla

et al. 2021

JCM

View full text Add to dashboard Cite

Objectives: Acceptance and commitment therapy (ACT) is considered by the American Psychological Association as an evidence-based treatment for a variety of disorders, including chronic pain. The main objective of the present systematic review was to determine the effectiveness of ACT in patients with central pain sensitization syndromes (CPSS). Methods: This systematic review was conducted according to the guidelines of the Cochrane Collaboration and PRISMA statements. The protocol was registered in advance in the Prospective Register of Systematic Reviews (PROSPERO) international database. The selected articles were evaluated using the Cochrane risk of bias (ROB) assessment tool. The PubMed, Scopus, and Web of Science databases were searched. Results: The literature search identified 21 studies (including investigations of fibromyalgia syndrome, irritable bowel syndrome, and migraine) eligible for the systematic review. There were no studies regarding the effectiveness of ACT for chronic tension-type headache (CTTH), interstitial cystitis (IC), or temporomandibular disorder (TMD). The evaluation of ROB showed that 12 of the selected studies were of low quality, 5 were of moderate quality, and 4 were high quality. ACT reduces some clinical symptoms, such as anxiety, depression, and pain. This positive effect of ACT might be mediated by pain acceptance, psychological flexibility, optimism, self-efficacy, or adherence to values. ACT showed better results in comparison to non-intervention (e.g., “waiting list”) conditions, as well as pharmacological and psychoeducational interventions. It is not entirely clear whether extended ACT treatments are more advantageous than briefer interventions. Conclusions: There are few studies about the effectiveness of ACT on CPSS. However, ACT seems to reduce subjective CPSS symptoms and improve the health-related quality of life of these patients. The absence of studies on the effectiveness of ACT in CTTH, IC, and TMD, indicate the pressing need for further ACT studies in these CPSS.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Effectiveness of Acceptance and Commitment Therapy in Central Pain Sensitization Syndromes: A Systematic Review

Galvez-Sánchez

Montoro

Moreno-Padilla

et al. 2021

JCM

View full text Add to dashboard Cite

show abstract

“…48,49 Disability resulting from headache disorders has been linked with avoidant coping, 50 leading to the development of the Headache Acceptance Questionnaire 51 ; and some preliminary reports have suggested the value of ACT for relieving headaches. 52,53 The related approach of Mindfulness-Based Cognitive Therapy seems to also have value for reducing headache disability. [54][55][56] A series of laboratory investigations has been carried out to test the TAMH.…”

Section: How Do Triggers Acquire the Capacity To Precipitate Headaches?mentioning

confidence: 99%

Triggers of Primary Headaches: Issues and Pathways Forward

Martin

2020

Headache

View full text Add to dashboard Cite

The triggers of primary headaches have considerable significance for our understanding and management of headache and migraine. Triggers explain the variance in headaches – why they occur when they do. Trigger management is generally viewed as an important component of a comprehensive treatment approach for headaches. Historically, however, triggers have not had a prominent place in the headache literature. This situation began to change 20 to 30 years ago, and the pace of change has increased exponentially in recent times. Nevertheless, the field is beset with issues that have held it back from achieving more. This review will focus on elaborating those issues with the goal of suggesting ways forward. The first issue considered will be the definition of a trigger, and how specific triggers are labeled. Consideration will then be given to a classification system for triggers. The review will discuss next the evidence relating to whether self‐reported triggers can, indeed, precipitate headaches, and how the capacity to elicit headaches may be acquired or extinguished. Attention will be given to the very important clinical issue of trigger management. Finally, the pathways forward will be proposed. Perhaps the most useful thing to accomplish at this point in time would be agreement on a definition of headache triggers, a list of triggers, and a classification system for triggers. This would greatly assist in comparing research on triggers from different research groups as well as eliminating some of the issues identified in this review. An authoritative body such as the American Headache Society or the International Headache Society, could establish a multidisciplinary committee that would complete these tasks. Consideration should also be given to incorporating triggers into the International Classification of Headache Disorders as an axis or via the use of codes, as this would raise the profile of triggers in assessment and management.

show abstract

Headache and Migraine

Martin

2022

Comprehensive Clinical Psychology

View full text Add to dashboard Cite

Acceptance and Commitment Therapy (ACT) vs Erenumab for High Frequency Episodic Migraine Without Aura: Time to Take the Gloves Off!

Cited by 7 publications

References 11 publications

Effectiveness of Acceptance and Commitment Therapy in Central Pain Sensitization Syndromes: A Systematic Review

Effectiveness of Acceptance and Commitment Therapy in Central Pain Sensitization Syndromes: A Systematic Review

Triggers of Primary Headaches: Issues and Pathways Forward

Headache and Migraine

Contact Info

Product

Resources

About